ArticleBioMed research international2015

The use of an IL-1 receptor antagonist peptide to control inflammation in the treatment of corneal limbal epithelial stem cell deficiency.

E Fok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.